SCHEMBL2865036

SCHEMBL2865036

O=C(Nc1cccc(-c2n[nH]c3ccc(NC(=O)C4CC4)cc23)c1)C1CC1

nearest known ligand 0.65

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 3/20 0.65
ULK1 O75385 3/20 0.62
ITK Q08881 3/20 0.60
CSNK2A1 P68400 1/20 0.60
AAK1 Q2M2I8 2/20 0.58
AURKA O14965 4/20 0.57
TTK P33981 3/20 0.54
MAP2K7 O14733 1/20 0.53
MAPK8 P45983 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5381639 0.89 AAK1 (0.59) PDPK1ULK1ITKCSNK2A1AAK1
SCHEMBL2871320 0.86 PDPK1 (0.66) PDPK1ULK1ITKCSNK2A1
SCHEMBL5381303 0.85 AAK1 (0.52) PDPK1ULK1ITKCSNK2A1AAK1
SCHEMBL6545151 0.84 TTK (0.49) PDPK1ULK1ITKCSNK2A1AAK1
SCHEMBL8251891 0.84 ULK1 (0.61) PDPK1ULK1ITK
SCHEMBL10214710 0.84 MAPKAPK2 (0.58) PDPK1ULK1ITK
SCHEMBL8254064 0.84 ULK1 (0.59) PDPK1ULK1ITKCSNK2A1AAK1
SCHEMBL5377953 0.81 CLK2 (0.53) PDPK1ITKCSNK2A1AAK1TTK
SCHEMBL2867415 0.81 ULK1 (0.64) PDPK1ULK1ITK
SCHEMBL13198185 0.81 PDPK1 (0.52) PDPK1ULK1ITKCSNK2A1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PDPK1 885/4885ULK1 893/4885ITK 3726/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 PDPK1 1320/4885ULK1 1315/4885ITK 3628/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PDPK1 885/4885ULK1 893/4885ITK 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.